Highlight of my career. James Allison ⁦The Nobel Prize⁩ Medicine 2018, Phil Sharp ⁦The Nobel Prize⁩ Medicine 1983, Carolyn Bertozzi ⁦The Nobel Prize⁩ Chemistry 2022, ⁦@PamSharmaMDPhD⁩ #Mentor. #Inspiring. ⁦MD Anderson Cancer Center⁩ #oncsurgery

Welcome, new cancer center directors! We hope you learned some valuable lessons from seasoned cancer center directors and enjoyed the opportunity to network with your peers. #AACI2024

Congratulations to our Dr. Funda Meric-Bernstam for being elected to the National Academy of Medicine for her contributions to precision oncology, therapeutics development and biomarker discovery. Read more: brnw.ch/21wNY10 National Academy of Medicine #EndCancer

Congrats to KI Director Matthew Vander Heiden @mvhlab on being elected to the National Academy of Medicine for 2024! @‌theNAMedicine election recognizes his leadership and pioneering work on cancer metabolism has paved the way for new therapies. buff.ly/3NBQIZn

This past weekend, we kicked off the fall season by volunteering at the Houston Arboretum ArBOOretum Family Festival. It was a wonderful experience watching kids and families come together to decorate pumpkins, get face paintings, and enjoy trick-or-treating on the trail.

Iconic photo featuring our own @JimAllisonPhD MD Anderson Cancer Center to mark the 40th anniversary of the discovery of the TCR. Sadelain reminding us of the engineered T cell flavor (CAR-T cells) with his “C”

The first BTC trial to target AML MRD with combination of menin and BCL2 inhibition is now open! Huge team effort and more exciting trials for MRD to come. Goal is to better measure, understand and treat MRD

“Spatial omics is an incredibly exciting field that’s evolving quickly,” our Dr. Linghua Wang shared at #SITC24. “Working closely with pathologists is especially important and can lead to unique insights.” Learn more about her work as an associate member of the James P. Allison

#RadicalCollaboration drives everything we do. Today, scientists and clinicians from around the country - including Dana-Farber,Johns Hopkins Medicine, Koch Institute at MIT, Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center - are on their way to the Break Through Cancer Summit 2024 in Houston, Texas to share

Dr. Jeffrey Molldrem of MD Anderson Cancer Center embodies the generosity, dedication, and collaborative spirit that drives #RadicalCollaboration at Break Through Cancer. As a leader within our AML TeamLabs, he’s built a culture of trust, inspiring transformative progress toward AML cures.

New commentary in Nature Biotechnology from MD Anderson Cancer Center Dihua Yu and colleagues: Turn cold tumors hot by reprogramming the tumor microenvironment nature.com/articles/s4158…

Anirban’s stellar leadership skills and exceptional talent will be sorely missed. You made a difference for us and I sincerely hope to be able to rely on you for many years to come! On behalf of our community, wish you all the best!

Raghu Kalluri NYU Langone Health Thank you so much Raghu 🙏🏽🙏🏽 The MD Anderson Cancer Center crowd stole the show yesterday evening. Congratulations to fellow inductees Katy Rezvani, M.D., Ph.D Scott Kopetz Giulio Draetta G Garcia-Manero & Jennifer Wargo MD. Thanks Bob Bast who attends the ASCI/AAP induction each year. A real mensch!

Thrilled to share this exciting study ⁦Nature Medicine⁩. Largest integrative analysis of #sotorasib efficacy biomarkers to date. Grateful to all co- investigators and the Amgen team for their hard work and most of all to our patients. ⁦MD Anderson Cancer Center⁩ #KRAS #NSCLC

I’m deeply honored to join the Cancer Cell Advisory Board! — a journal that’s shaped the field through high-impact, groundbreaking studies. Proud to serve alongside such an esteemed group of scientists advancing #CancerResearch

Please check out our paper published today in Nature that identifies CREM as a key checkpoint limiting CAR NK cell function.CRISPR knockout of CREM significantly enhanced anti-tumor activity, implicating a broader role in NK cell regulation. Huge congrats to @hindrafei and our

Huge congratulations to Xiling Shen MD Anderson Cancer Center and Ayelet Erez Weizmann Institute for their Cell paper: Vagal blockade of the brain-liver axis deters cancer-associated cachexia cell.com/cell/abstract/… Clinical trials in patients with #PancreaticCancer forthcoming!

Today we celebrate a major milestone: the approval of our treatment for people with #HER2-mutant advanced non-small cell lung cancer (NSCLC). This milestone is based on years of rigorous research. A big thank you to our teams for delivering meaningful solutions for patients.

Delighted to share our Cancer Cell paper published today, co-authored by Dr. Alexander Biederstädt Alexander Biederstädt, MD and Dr. Rafet Basar Rafet reporting the first genome-wide CRISPR screen in primary cord blood NK and CAR NK cells. We identify key genetic checkpoints including

New birthday, new city, new job, new beginnings! 🥳 Delighted to start in my new role at NYU Langone Health Perlmutter Cancer Center at NYU Langone Health. Looking forward to establishing a vibrant GI cancer center with Manuel Hidalgo 🇪🇸 🇺🇸 John P. Leonard, MD & other exceptional colleagues. ❤️ my commute - view from my window!